Francis Burrows serves as Executive at Kura Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Francis Burrows has executed 4 insider transactions totaling $243.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 27, 2026 involved selling 1,311 shares valued at $11.1K.
Francis Burrows currently holds 32,424 shares of Kura Oncology, Inc. (KURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Francis Burrows has been a net seller of KURA stock. They have purchased $0 and sold $243.1K worth of shares.
Francis Burrows's most recent insider trade was on Jan 27, 2026, when they sold 1,311 shares at $8.46 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 18, 2025 | KURA | $168.0K | Option Exercise | 35,000 | $4.80 | Discretionary |
| Dec 18, 2025 | KURA | $232.0K | Sale | 23,726 | $9.78 | Discretionary |